Non–Small Cell Lung Cancer: Other Actionable Mutations
2 Vues
• 07/04/23
0
0
Intégrer
administrator
Les abonnés
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires